CLOV
Clover Health Investments, Corp. · Healthcare · Medical - Healthcare Plans
Momentum-inputs (vergelijkbare managers): breedte van houders 0.0% · aandelenstroom +23.0% · netto nieuwe posities 0.0% — formule
Alle eigendomscijfers: uitsluitend gevolgde 13F-managers, posities in gewone aandelen, rapportageperiode Q1 2025
| Kwartaal | Houders | Δ | Aandelen | Gerapporteerde waarde | Nieuw | Uitstappen |
|---|---|---|---|---|---|---|
| Q2 2026 | 85 | +6 | 128.61M | $672.46M | +12 | −6 |
| Q1 2026 | 82 | +5 | 113.55M | $200.08M | +10 | −5 |
| Q4 2025 | 76 | -1 | 119.92M | $281.85M | — | −1 |
| Q3 2025 | 14 | -2 | 85.90M | $262.85M | — | −2 |
| Q2 2025 | 13 | +1 | 91.13M | $254.25M | +1 | — |
| Q1 2025 | 9 | 0 | 31.30M | $112.39M | +2 | −2 |
| Q4 2024 | 9 | 0 | 25.46M | $80.20M | — | — |
| Q3 2024 | 8 | +1 | 20.89M | $58.90M | +2 | −1 |
| Q2 2024 | 7 | — | 19.27M | $23.70M | — | — |
| # | Manager | Aandelen | Δ aandelen | Waarde | Hun gewicht | Gehouden | ||
|---|---|---|---|---|---|---|---|---|
| 1 | Renaissance Technologies ✦ | 11.02M | -0.4% | $39.58M | 0.1% | ▼ Trim | 4 | SEC ↗ |
| 2 | Millennium Management ✦ | 5.80M | +365.9% | $20.84M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 3 | Geode Capital Management ✦ (passief) | 5.03M | +3.0% | $18.07M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 4 | Geode Capital Management ✦ (passief) | 5.03M | +3.0% | $18.07M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 5 | Marshall Wace ✦ | 4.58M | +21.4% | $16.43M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 6 | Marshall Wace ✦ | 4.58M | +21.4% | $16.43M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 7 | Marshall Wace ✦ | 4.58M | +21.4% | $16.43M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 8 | State Street Global Advisors ✦ (passief) | 2.93M | +4.6% | $10.51M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 9 | Citadel Advisors ✦ | 1.73M | +90.3% | $6.23M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 10 | Citadel Advisors ✦ | 1.73M | +90.3% | $6.23M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 11 | T. Rowe Price ✦ | 152.50K | Nieuw | $548,000 | 0.0% | New | 1 | SEC ↗ |
| 12 | Gotham Asset Management ✦ | 40.93K | -4.7% | $146,928 | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 13 | AQR Capital Management ✦ | 13.58K | Nieuw | $48,738 | 0.0% | New | 1 | SEC ↗ |
| 14 | AQR Capital Management ✦ | 13.58K | Nieuw | $48,738 | 0.0% | New | 1 | SEC ↗ |
| 15 | AQR Capital Management ✦ | 13.58K | Nieuw | $48,738 | 0.0% | New | 1 | SEC ↗ |
| 16 | AQR Capital Management ✦ | 13.58K | Nieuw | $48,738 | 0.0% | New | 1 | SEC ↗ |
"Hun gewicht" = het aandeel van de positie in de gerapporteerde 13F-aandelenwaarde van die beheerder — de overtuigingsmaatstaf. ✦ = gecureerde beheerder.
Nieuwe kopers
| T. Rowe Price | $548,000 | 0.0% |
| AQR Capital Management | $48,738 | 0.0% |
| AQR Capital Management | $48,738 | 0.0% |
| AQR Capital Management | $48,738 | 0.0% |
| AQR Capital Management | $48,738 | 0.0% |
Verlaten
| Two Sigma Investments | $1.59M | was 0.0% |
| Point72 Asset Management | $747,180 | was 0.0% |
Volledige marktcontext: over ALLE 13F-indieners (SEC gestructureerde data, Q1 2026): 207 houders, 127.13M aandelen, $218.62M gerapporteerd. Dit betreft een andere, oudere periode dan de bovenstaande cijfers van het gevolgde universum; beide worden nooit gecombineerd.
Wat de gevolgde houders van dit effect verder het vaakst bezitten — aantallen gedeeld eigendom, geen fundamentele relaties.
Open-market aankopen (P)
Geen open-market insider-aankopen in ons dekkingsvenster.
Open-market verkopen (S)
Officer · 17.77K aand · $78,032
Officer, Director · 87.80K aand · $408,261
Toekenningen, uitoefeningen en belastinginhoudingen worden hier nooit meegeteld als aankopen of verkopen. Methodologie